---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-158374"
form_type: "8-K"
ticker: "FATE"
cik: "0001434316"
company_name: "FATE THERAPEUTICS INC"
filed_at: "2024-06-10T23:59:59+00:00"
generated_at: "2026-06-01T05:16:19.617051+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Fate Therapeutics stockholders approve charter amendment to exculpate officers

## Summary
- Certificate of Amendment to Amended and Restated Certificate of Incorporation approved by stockholders at Annual Meeting on June 7, 2024.
- Amendment allows exculpation of certain officers, limiting personal liability for breaches of fiduciary duty.
- Effective upon filing with Delaware Secretary of State on June 7, 2024.
- Board recommended the amendment; stockholders voted to approve.

## SEC filing metadata
- accession: 0001193125-24-158374
- form_type: 8-K
- ticker: FATE
- cik: 0001434316
- company_name: FATE THERAPEUTICS INC
- filed_at: 2024-06-10T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1434316/000119312524158374/0001193125-24-158374-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1434316/000119312524158374/d764437d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-158374
- JSON: https://secwatch.observer/filing/0001193125-24-158374.json
- Plain text: https://secwatch.observer/filing/0001193125-24-158374.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.